Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lindeman

Showing results (221-230 of 292) with videos related to

Pageof 30
Sort By:
The Journal of Biological Chemistry|April 16, 2004
Dimerization of CtIP, a BRCA1- and CtBP-interacting protein, is mediated by an N-terminal coiled-coil motifManu J Dubin, Philippa H Stokes, Eleanor Y M Sum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2007
Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast CancerSarah-Jane Dawson, Melanie A Price, Mark A Jenkins, et al.
British Journal of Cancer|May 13, 2020
Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysisKelly A Metcalfe, Melanie A Price, Carol Mansfield, et al.
Familial Cancer|June 14, 2005
Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohortKelly-Anne Phillips, Phyllis N Butow, Ailsa E Stewart, et al.
Nature Cell Biology|December 26, 2006
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiationMarie-Liesse Asselin-Labat, Kate D Sutherland, Holly Barker, et al.
Breast Cancer Research and Treatment|June 8, 2019
Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokineticsVéronique Diéras, Hervé Bonnefoi, Emilio Alba, et al.
Cancer Cell|July 13, 2013
Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancerFrançois Vaillant, Delphine Merino, Lily Lee, et al.
Breast Cancer Research : BCR|June 30, 2021
Single cell transcriptome atlas of mouse mammary epithelial cells across developmentBhupinder Pal, Yunshun Chen, Michael J G Milevskiy, et al.
Cell Reports|December 19, 2024
Hormone-responsive progenitors have a unique identity and exhibit high motility during mammary morphogenesisCaleb A Dawson, Michael J G Milevskiy, Bianca D Capaldo, et al.
The EMBO Journal|December 2, 2006
c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3Kate D Sutherland, François Vaillant, Warren S Alexander, et al.
Pageof 30

Showing results (221-230 of 292) with videos related to

Sort By:
Pageof 30
The Journal of Biological Chemistry|April 16, 2004
Dimerization of CtIP, a BRCA1- and CtBP-interacting protein, is mediated by an N-terminal coiled-coil motifManu J Dubin, Philippa H Stokes, Eleanor Y M Sum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2007
Cancer risk management practices of noncarriers within BRCA1/2 mutation positive families in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast CancerSarah-Jane Dawson, Melanie A Price, Mark A Jenkins, et al.
British Journal of Cancer|May 13, 2020
Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysisKelly A Metcalfe, Melanie A Price, Carol Mansfield, et al.
Familial Cancer|June 14, 2005
Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohortKelly-Anne Phillips, Phyllis N Butow, Ailsa E Stewart, et al.
Nature Cell Biology|December 26, 2006
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiationMarie-Liesse Asselin-Labat, Kate D Sutherland, Holly Barker, et al.
Breast Cancer Research and Treatment|June 8, 2019
Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokineticsVéronique Diéras, Hervé Bonnefoi, Emilio Alba, et al.
Cancer Cell|July 13, 2013
Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancerFrançois Vaillant, Delphine Merino, Lily Lee, et al.
Breast Cancer Research : BCR|June 30, 2021
Single cell transcriptome atlas of mouse mammary epithelial cells across developmentBhupinder Pal, Yunshun Chen, Michael J G Milevskiy, et al.
Cell Reports|December 19, 2024
Hormone-responsive progenitors have a unique identity and exhibit high motility during mammary morphogenesisCaleb A Dawson, Michael J G Milevskiy, Bianca D Capaldo, et al.
The EMBO Journal|December 2, 2006
c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3Kate D Sutherland, François Vaillant, Warren S Alexander, et al.
Pageof 30